Pityriasis rosea
Showing 1 - 25 of 101
Pityriasis Alba Trial in Tashkent (Detection of Plasma levels of 25(OH) vitamin D by ELISA technique, Detection of Total serum
Active, not recruiting
- Pityriasis Alba
- Detection of Plasma levels of 25(OH) vitamin D by ELISA technique
- Detection of Total serum immunoglobulin E by ELISA technique
-
Tashkent, Uchtepa, UzbekistanResearch institute of epidemiology, microbiology and infectious
Sep 13, 2021
Pityriasis Alba Trial in Beirut (Elidel (pimecrolimus 1%), Cold Cream)
Unknown status
- Pityriasis Alba
- Elidel (pimecrolimus 1%)
- Cold Cream
-
Beirut, LebanonSaint Joseph University
Feb 7, 2019
Cutaneous Manifestations, Skin Manifestations, COVID-19 Trial in Karachi
Completed
- Cutaneous Manifestations
- +7 more
-
Karachi, Sindh, PakistanJinnah Postgraduate Medical Centre
Nov 12, 2021
Tinea Versicolor Trial in Abbottabad (Fluconazole, Itraconazole)
Completed
- Tinea Versicolor
-
Abbottābād, Khyber Pakhtunkhwa, PakistanCMH Abbottabad
May 8, 2023
Burn Out, Psychological Disturbance Trial in Lille (Meta 18.06 Day and Meta 18.06 Night, Placebo Meta 18.06 Day and Placebo Meta
Completed
- Burn Out
- Psychological Disturbance
- Meta 18.06 Day and Meta 18.06 Night
- Placebo Meta 18.06 Day and Placebo Meta 18.06 Night
-
Lille, Nord, FranceNutrInvest - Institut Pasteur de Lille
Dec 6, 2022
NOMID, CINCA Syndrome Trial run by the (Canakinumab)
Terminated
- NOMID
- CINCA Syndrome
-
Bethesda, MarylandNational Institute of Arthritis and Musculoskeletal and Skin Dis
Jun 9, 2021
Vitamin D Level in Recurrent PV
Recruiting
- Recurrent Pityriasis Versicolor
- Human 25-Hydroxyvitamin D3 (HVD3) ELISA Kit (96 well)
-
Cairo, EgyptKasr Al Ainy Teaching Hospital
Sep 24, 2021
Parkinson Disease Trial in Ibadan (Hypoestoxide)
Enrolling by invitation
- Parkinson Disease
-
Ibadan, OYO, NigeriaCollege of Medicine, University of Ibadan
Jan 20, 2022
Pityriasis Rubra Pilaris Trial in Portland (guselkumab)
Active, not recruiting
- Pityriasis Rubra Pilaris
- guselkumab
-
Portland, OregonOregon Health and Science University
Apr 8, 2022
Covid19 Trial in Tbilisi (ADAPT-232 oral solution, Placebo oral solution)
Completed
- Covid19
- ADAPT-232 oral solution
- Placebo oral solution
-
Tbilisi, GeorgiaNational Family Medicine Training Centre,
Dec 27, 2021
HIV Trial in United States (MPER-656 Liposome Vaccine, Placebo for MPER-656 Liposome Vaccine)
Completed
- HIV Infections
- MPER-656 Liposome Vaccine
- Placebo for MPER-656 Liposome Vaccine
-
Birmingham, Alabama
- +5 more
Jun 15, 2022
Malassezia Species Isolated From Malassezia Associated Skin
Not yet recruiting
- Malassezia Infection
- culture and antifungal sensitivity and molecular detection
-
Sohag, EgyptSohag University Hospital
Jul 25, 2022
HIV Trial in Puerto Rico, United States (Didanosine (ddI), Efavirenz (EFV), Emtricitabine (FTC))
Completed
- HIV Infections
- Didanosine (ddI)
- +2 more
-
San Diego, California
- +17 more
Nov 3, 2021
Enthesitis Related Arthritis (ERA) Trial (adalimumab, for adalimumab)
Completed
- Enthesitis Related Arthritis (ERA)
- adalimumab
- placebo for adalimumab
- (no location specified)
Jul 8, 2021
Severe Aplastic Anemia, Refractory, Severe Aplastic Anemia, Relapse Trial run by the NHLBI (Alemtuzumab (Campath ),
Completed
- Severe Aplastic Anemia, Refractory
- Severe Aplastic Anemia, Relapse
- Alemtuzumab (Campath )
- Cyclosporine
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 29, 2020
Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Dystrophinopathy Trial in Worldwide (Ataluren)
Completed
- Duchenne Muscular Dystrophy
- +2 more
-
Parkville, Melbourne, Australia
- +20 more
Nov 3, 2020
Pulmonary Arterial Hypertension Trial in Worldwide (UT-15C (treprostinil diolamine))
Completed
- Pulmonary Arterial Hypertension
- UT-15C (treprostinil diolamine)
-
Phoenix, Arizona
- +152 more
May 6, 2022
Septal Defect, Atrial Trial in Charlottesville (GORE® CARDIOFORM Septal Occluder)
Completed
- Septal Defect, Atrial
- GORE® CARDIOFORM Septal Occluder
-
Charlottesville, VirginiaUniversity of Virginia, Children's Hospital Heart Center
Aug 10, 2020
COVID-19 Trial in Worldwide (AZD7442, Placebo)
Menopause Trial in Tbilisi (Menopause Relief EP-40, Low Dose Black Cohosh, High Dose Black Cohosh)
Completed
- Menopause
- Menopause Relief EP-40
- +3 more
-
Tbilisi, GeorgiaI.Zhordania Institute of Reproductology
Apr 27, 2020
Coronary Microvascular Disease Trial (Rhodiola Rosea Capsules, Placebo)
Not yet recruiting
- Coronary Microvascular Disease
- Rhodiola Rosea Capsules
- Placebo
- (no location specified)
Jan 3, 2020